Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Geistlich Pharma AG

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Geistlich Pharma AG

Regulatory records
3
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 3 FDA records to the applicant name Geistlich Pharma AG. The collection includes 3 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jan 22, 2026 to Jun 2, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code KGN appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

Applicant mailing address recorded by FDA: Bahnhofstrasse 40, Wolhusen, 6110, CH. Recorded on K260364, decision dated Jun 2, 2026.

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Geistlich Pharma AG510(k) clearanceJun 2, 2026FDA
Derma-GideK260532
Geistlich Pharma AG510(k) clearanceMar 19, 2026FDA
Geistlich Pharma AG510(k) clearanceJan 22, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.